Literature DB >> 23083863

Tumor complexity predicts malignant disease for small renal masses.

Jeffrey K Mullins1, Jihad H Kaouk, Sam Bhayani, Craig G Rogers, Michael D Stifelman, Phillip M Pierorazio, Youssef S Tanagho, Shahab P Hillyer, Bartosz F Kaczmarek, Yichun Chiu, Mohamad E Allaf.   

Abstract

PURPOSE: Approximately 20% to 30% of suspicious small renal tumors are benign. A significant proportion of malignant tumors are low grade and potentially indolent. We evaluated whether preoperative patient and tumor characteristics are associated with adverse pathological features.
MATERIALS AND METHODS: A total of 886 patients underwent robot-assisted partial nephrectomy, as done by 1 of 5 high volume surgeons. Demographic and clinical data were compared between patients with benign/malignant disease, clear cell/nonclear cell renal cell carcinoma and high/low grade tumors. Tumor complexity was quantified by R.E.N.A.L. (radius, exophytic/endophytic, nearness of tumor to collecting system or sinus, anterior/posterior, hilar and location relative to polar lines) nephrometry score and described as low--4 to 6, intermediate--7 to 9 or high--10 or greater. Logistic regression analyses were performed to test the association between tumor and patient characteristics, and high grade renal cell carcinoma. Subanalyses were done for patients with renal tumors 4 cm or less.
RESULTS: High grade renal cell carcinoma was larger and more likely to develop in men. Patients with malignant tumors and with clear cell histology were more likely to have intermediate or high complexity tumors. Increasing tumor complexity independently predicted malignancy, high grade malignancy and clear cell histology on multivariate regression analysis (each p <0.05). Male gender was independently associated with malignancy and high grade renal cell carcinoma. When considering tumors 4 cm or less, tumor complexity predicted malignancy but not tumor grade.
CONCLUSIONS: High R.E.N.A.L nephrometry score and male gender are associated with an increased risk of malignancy and high grade malignancy in tumors treated with partial nephrectomy.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23083863     DOI: 10.1016/j.juro.2012.08.027

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?

Authors:  Reza Mehrazin; Marc C Smaldone; Brian Egleston; Jeffrey J Tomaszewski; Charles W Concodora; Timothy K Ito; Philip H Abbosh; David Y T Chen; Alexander Kutikov; Robert G Uzzo
Journal:  Urol Oncol       Date:  2015-03-14       Impact factor: 3.498

2.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 3.  Gender differences in benign renal masses.

Authors:  Julian Mauermann; Michela de Martino; Matthias Waldert; Andrea Haitel; Hans Christoph Klingler; Mesut Remzi; Tobias Klatte
Journal:  World J Urol       Date:  2013-02-16       Impact factor: 4.226

4.  Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia.

Authors:  Dong Soo Park; Jin Ho Hwang; Moon Hyung Kang; Jong Jin Oh
Journal:  Can Urol Assoc J       Date:  2014 Mar-Apr       Impact factor: 1.862

5.  Evaluation of the Clinical Use of Robot-Assisted Retroperitoneal Laparoscopy and Preoperative RENAL Scoring for Nephron Sparing Surgery in Renal Tumor Patients.

Authors:  Yu Xia; Gong-Xian Wang; Bin Fu; Wei-Peng Liu; Cheng Zhang; Xiao-Chen Zhou
Journal:  Indian J Surg       Date:  2016-12-26       Impact factor: 0.656

6.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

Review 7.  A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Authors:  Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill
Journal:  Eur Urol       Date:  2015-04-22       Impact factor: 20.096

8.  Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China.

Authors:  Ning Liu; Feng Qu; Qiancheng Shi; Wenyuan Zhuang; Wenliang Ma; Zhenhao Yang; Jing Sun; Wei Xu; Lihua Zhang; Ruipeng Jia; Linfeng Xu; Xiaozhi Zhao; Xiaogong Li; Gutian Zhang; Hongqian Guo; Dongmei Li; Weidong Gan
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

9.  Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Jae Hyeok Choi; Jong Won Kim; Joo Yong Lee; Woong Kyu Han; Koon Ho Rha; Young Deuk Choi; Sung Joon Hong; Young Eun Yoon
Journal:  Korean J Urol       Date:  2015-10-06

10.  R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.

Authors:  Akira Nagahara; Motohide Uemura; Atsunari Kawashima; Takeshi Ujike; Kazutoshi Fujita; Yasushi Miyagawa; Norio Nonomura
Journal:  Int J Clin Oncol       Date:  2015-07-29       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.